WallStreetZenWallStreetZen

NASDAQ: DTIL
Precision Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DTIL

Based on 2 analysts offering 12 month price targets for Precision Biosciences Inc.
Min Forecast
$19.00+102.13%
Avg Forecast
$39.50+320.21%
Max Forecast
$60.00+538.3%

Should I buy or sell DTIL stock?

Based on 2 analysts offering ratings for Precision Biosciences Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DTIL stock forecasts and price targets.

DTIL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-22
lockedlocked$00.00+00.00%2024-04-30

1 of 1

Forecast return on equity

Is DTIL forecast to generate an efficient return?
Company
1.84%
Industry
-752.51%
Market
49.24%
DTIL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DTIL forecast to generate an efficient return on assets?
Company
0.83%
Industry
26.49%
DTIL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DTIL earnings per share forecast

What is DTIL's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$0.82+141.18%
Avg 2 year Forecast
-$1.06-411.76%
Avg 3 year Forecast
$0.06-82.35%

DTIL revenue forecast

What is DTIL's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$85.4M-2.56%
Avg 2 year Forecast
$45.6M-47.97%
Avg 3 year Forecast
$66.5M-24.12%
DTIL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DTIL revenue growth forecast

How is DTIL forecast to perform vs Biotechnology companies and vs the US market?
Company
-8.79%
Industry
35.81%
Market
9.63%
DTIL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DTIL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DTIL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DTIL$9.40$39.50+320.21%Strong Buy
ENTX$1.87$10.00+434.76%Buy
DBVT$0.70$5.00+614.29%Buy
OSTX$3.28$21.00+540.24%Strong Buy
ANL$1.88$9.00+378.72%Buy
View Top Biotech Stocks

Precision Biosciences Stock Forecast FAQ

Is Precision Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: DTIL) stock is to Strong Buy DTIL stock.

Out of 2 analysts, 1 (50%) are recommending DTIL as a Strong Buy, 1 (50%) are recommending DTIL as a Buy, 0 (0%) are recommending DTIL as a Hold, 0 (0%) are recommending DTIL as a Sell, and 0 (0%) are recommending DTIL as a Strong Sell.

If you're new to stock investing, here's how to buy Precision Biosciences stock.

What is DTIL's earnings growth forecast for 2024-2026?

(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.7%.

Precision Biosciences's earnings in 2024 is $16,969,000.On average, 1 Wall Street analyst forecast DTIL's earnings for 2024 to be $5,931,683, with the lowest DTIL earnings forecast at $5,931,683, and the highest DTIL earnings forecast at $5,931,683. On average, 1 Wall Street analyst forecast DTIL's earnings for 2025 to be -$7,667,786, with the lowest DTIL earnings forecast at -$7,667,786, and the highest DTIL earnings forecast at -$7,667,786.

In 2026, DTIL is forecast to generate $434,026 in earnings, with the lowest earnings forecast at $434,026 and the highest earnings forecast at $434,026.

What is DTIL's revenue growth forecast for 2024-2026?

(NASDAQ: DTIL) Precision Biosciences's forecast annual revenue growth rate of -8.79% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.63%.

Precision Biosciences's revenue in 2024 is $87,640,000.On average, 1 Wall Street analysts forecast DTIL's revenue for 2024 to be $617,763,104, with the lowest DTIL revenue forecast at $617,763,104, and the highest DTIL revenue forecast at $617,763,104. On average, 1 Wall Street analysts forecast DTIL's revenue for 2025 to be $329,859,456, with the lowest DTIL revenue forecast at $329,859,456, and the highest DTIL revenue forecast at $329,859,456.

In 2026, DTIL is forecast to generate $481,045,040 in revenue, with the lowest revenue forecast at $481,045,040 and the highest revenue forecast at $481,045,040.

What is DTIL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DTIL) forecast ROA is 0.83%, which is lower than the forecast US Biotechnology industry average of 26.49%.

What is DTIL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year DTIL price target, the average DTIL price target is $39.50, with the highest DTIL stock price forecast at $60.00 and the lowest DTIL stock price forecast at $19.00.

On average, Wall Street analysts predict that Precision Biosciences's share price could reach $39.50 by Aug 22, 2025. The average Precision Biosciences stock price prediction forecasts a potential upside of 320.21% from the current DTIL share price of $9.40.

What is DTIL's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: DTIL) Precision Biosciences's current Earnings Per Share (EPS) is $0.34. On average, analysts forecast that DTIL's EPS will be $0.82 for 2024, with the lowest EPS forecast at $0.82, and the highest EPS forecast at $0.82. On average, analysts forecast that DTIL's EPS will be -$1.06 for 2025, with the lowest EPS forecast at -$1.06, and the highest EPS forecast at -$1.06. In 2026, DTIL's EPS is forecast to hit $0.06 (min: $0.06, max: $0.06).

What is DTIL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DTIL) forecast ROE is 1.84%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.